Related Experiment Videos
[Fulminant hepatitis: pathogenesis, clinical aspects and management]
P M Ambühl1, P E Ballmer, S Krähenbühl
1Klinik B für Innere Medizin, Kantonsspital, St. Gallen.
Schweizerische Medizinische Wochenschrift
|March 5, 1994
Summary
Fulminant hepatic failure, a severe liver condition, is often caused by infections, drugs, or toxins. Early recognition and management of complications are crucial for improving patient outcomes.
Area of Science:
- Hepatology
- Critical Care Medicine
- Toxicology
Background:
- Fulminant hepatic failure (FHF) is a severe complication of diverse liver diseases.
- Infectious agents, drug toxicity, and environmental toxins are primary etiological factors.
- The liver's central role in metabolism means its failure impacts multiple organ systems.
Observation:
- Acute hepatic failure significantly impairs systemic organ function.
- High mortality rates (≥50%) are primarily linked to cerebral edema, gastrointestinal hemorrhage, and disseminated infections.
- Clinical presentation is complex, often leading to fatal outcomes.
Findings:
- This review details the causes, complications, and pathophysiology of FHF.
- It emphasizes strategies for preventing complications and therapeutic interventions.
- Prognostic assessment criteria are also discussed.
Implications:
- Understanding FHF pathophysiology is key to developing targeted treatments.
- Effective complication management and prognosis assessment can improve survival rates.
- Further research into novel therapeutic strategies for FHF is warranted.